Patients treated with a tumor necrosis factor-α inhibitor are more likely to develop extrapulmonary tuberculosis

Παρόμοια τεκμήρια

• Tumor necrosis factor-α inhibitor use in patients with malignancy: is it safe?
  ανά: Oh, Gyu Man, κ.ά.
  Έκδοση: (2020)
• Uveitis Reactivation in Children Treated with Tumor Necrosis Factor-α Inhibitors
  ανά: Lerman, Melissa A., κ.ά.
  Έκδοση: (2015)
• Senile/solar purpura like lesions developed in association with use of tumor necrosis factor-α (TNF-α) inhibitors
  ανά: Anca Chiriac, κ.ά.
  Έκδοση: (2014-01-01)
• Unusual location of tuberculosis in the course of tumor necrosis factor α inhibitor therapy
  ανά: Bielewicz-Zielińska, Agnieszka, κ.ά.
  Έκδοση: (2015)
• Clinical characteristics and treatment responses of patients who developed tuberculosis following use of a tumor necrosis factor-α inhibitor
  ανά: Chung, Keun Bum, κ.ά.
  Έκδοση: (2013)